TSE:2408 stock news
This page provides real-time market news, earnings updates, and company announcements related to KG Intelligence Co., Ltd. (TSE:2408).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-24 17:43 JST
NovaBridge Announces Productive FDA Type B Meeting on Potential Accelerated Approval Pathway for Givastomig in Gastric Cancer
Finviz2026-03-16 11:03:47
CytomX Therapeutics' Pivotal Trial Endpoints and Diarrhea Prophylaxis Plans Don’t Match
101 finance2026-03-16 14:42:35
Perspective Therapeutics Provides Recent Business Highlights and Reports Full Year 2025 Results
Finviz2026-03-16 20:12:46
MP Materials' $1.8B War Chest Funds $500M+ 10X Facility Buildout as Price Floor Guards Earnings
101 finance2026-03-16 22:31:06
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Nuwellis Completes Acquisition of Rendiatech
Finviz2026-03-17 12:03:50
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Finviz2026-03-17 12:09:49
Is Resmed Shares a Smart Addition to Your Investment Portfolio at This Time?
101 finance2026-03-17 16:09:47
Galectin's decision to appoint Dr. Brem enhances its reputation as it prepares for the important March 10 KOL event.
101 finance2026-03-18 08:12:41
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD)
Finviz2026-03-18 12:03:48
Protalix Biotherapeutics' Earnings Call Highlights Shifting EU Dosing Timelines and PRX-115 Trial Delays
101 finance2026-03-18 13:18:42
PLX’s $25M Achievement Extends Runway, Yet Balancing Cash Usage and Pipeline Progress Continues to Be a Risky Bet
101 finance2026-03-18 19:33:56
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes
Finviz2026-03-19 10:49:01
Johnson & Johnson Shares Edge Up 0.13% on 47th-Ranked $1.78B Volume Despite FDA Approval of Icotyde
101 finance2026-03-19 22:32:04
Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting
Finviz2026-03-20 14:06:49
Equinor’s strategic overhaul enables the company to capitalize on fluctuating energy markets and limited supply conditions.
101 finance2026-03-21 01:33:53
NKTR Traders Confront Legal Binary Deadline Against Forthcoming Clinical Milestone at AAD 2026
101 finance2026-03-23 05:39:38
MP Materials' "Warp Speed" Story Fuels Bullish FOMO, Yet Stock Declines as Investors Take Profits and Momentum Slows
101 finance2026-03-23 08:31:13
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:04:13
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies
Finviz2026-03-23 13:01:26
MIRA Explodes 23% on Groundbreaking Pain Research; Can This Surge Sustain?
101 finance2026-03-23 17:12:45
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-23 20:09:49
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Finviz2026-03-23 20:36:10
Nektar Therapeutics Faces High-Stakes AAD Data Test as Sky-High Valuation Leaves Little Room for Error
101 finance2026-03-24 02:30:40
Acumen Pharmaceuticals Presents Studies on Enhanced Brain Delivery, Biomarker Research, and Novel Antibodies at Advances in Alzheimer's Treatment at International Conference on Alzheimer's and Parkinson's Diseases 2026
Finviz2026-03-17 12:03:54
Nuwellis Completes Acquisition of Rendiatech
Finviz2026-03-17 12:03:50
Candel Therapeutics Reports Extended Survival Tail Observed in Trial of Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
Finviz2026-03-17 12:09:49
Is Resmed Shares a Smart Addition to Your Investment Portfolio at This Time?
101 finance2026-03-17 16:09:47
Galectin's decision to appoint Dr. Brem enhances its reputation as it prepares for the important March 10 KOL event.
101 finance2026-03-18 08:12:41
ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer's Disease/Parkinson's Disease 2026 International Conference (AD/PD)
Finviz2026-03-18 12:03:48
Protalix Biotherapeutics' Earnings Call Highlights Shifting EU Dosing Timelines and PRX-115 Trial Delays
101 finance2026-03-18 13:18:42
PLX’s $25M Achievement Extends Runway, Yet Balancing Cash Usage and Pipeline Progress Continues to Be a Risky Bet
101 finance2026-03-18 19:33:56
Lilly's triple agonist, retatrutide, demonstrated significant reductions in A1C and weight in first Phase 3 trial for treatment of type 2 diabetes
Finviz2026-03-19 10:49:01
Johnson & Johnson Shares Edge Up 0.13% on 47th-Ranked $1.78B Volume Despite FDA Approval of Icotyde
101 finance2026-03-19 22:32:04
Data from Phase 2b Studies for Rezpegaldesleukin Accepted for Two Oral Presentations at the 2026 American Academy of Dermatology Annual Meeting
Finviz2026-03-20 14:06:49
Equinor’s strategic overhaul enables the company to capitalize on fluctuating energy markets and limited supply conditions.
101 finance2026-03-21 01:33:53
NKTR Traders Confront Legal Binary Deadline Against Forthcoming Clinical Milestone at AAD 2026
101 finance2026-03-23 05:39:38
MP Materials' "Warp Speed" Story Fuels Bullish FOMO, Yet Stock Declines as Investors Take Profits and Momentum Slows
101 finance2026-03-23 08:31:13
Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-23 11:04:13
MIRA Pharmaceuticals Reports Mira-55 Shows No THC- or Rimonabant-Associated CNS Side Effects in Preclinical Studies
Finviz2026-03-23 13:01:26
MIRA Explodes 23% on Groundbreaking Pain Research; Can This Surge Sustain?
101 finance2026-03-23 17:12:45
Sutro Biopharma Reports Full Year 2025 Financial Results and Business Highlights
Finviz2026-03-23 20:09:49
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Finviz2026-03-23 20:36:10
Nektar Therapeutics Faces High-Stakes AAD Data Test as Sky-High Valuation Leaves Little Room for Error
101 finance2026-03-24 02:30:40
TSE:2408 stock price change
On the last trading day, TSE:2408 stock closed at 711.00 JPY, with a price change of -0.28% for the day.
Trade stock perpsTSE:2408 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more